For the Inventor, By the Inventor

Enter assignee name

Manchester, United Kingdom

Redx Pharma Limited

USPTO Granted Patents = 26

CIPO Patents = 3

EPO Patents = 12

Forward Citations = 73

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Inder Bhamra (9 out of 10 patents)

Richard Testar (8 out of 9 patents)

Craig Donoghue (7 out of 7 patents)

4. Matilda Bingham (6 out of 7 patents)

5. David John Moody (6 out of 7 patents)

6. Jonathan William Wiffen (6 out of 6 patents)

7. Louise Sargent (4 out of 4 patents)

8. Derek Lindsay (4 out of 5 patents)

9. Michael Mathieson (3 out of 3 patents)

10. Peter Jackson (3 out of 4 patents)

11. Clifford David Jones (3 out of 14 patents)

12. Thomas Pesnot (3 out of 5 patents)

13. Peter Bunyard (3 out of 3 patents)

14. Gary Pitt (3 out of 3 patents)

15. Liam Byrne (3 out of 3 patents)

26 patents: Sort by Forward Citations

1. 12453734 - Modulators of rho-associated protein kinase (2025-10-28),

2. 12202826 - N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway (2025-01-21),

3. 11878020 - Modulators of Rho-associated protein kinase (2024-01-23),

4. 11643408 - N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway (2023-05-09),

5. 11497751 - Modulators of Rho-associated protein kinase (2022-11-15),

6. 11459326 - N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors (2022-10-04),

7. 10793562 - N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors (2020-10-06),

8. 10793560 - N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway (2020-10-06),

9. 10487093 - Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds (2019-11-26),

10. 10385065 - Antibacterial compounds (2019-08-20),

11. 10202375 - N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors (2019-02-12),

12. 10183939 - Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers (2019-01-22),

13. 10047079 - N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway (2018-08-14),

14. 9850234 - Pyridine derivatives as soft rock inhibitors (2017-12-26),

15. 9682963 - Pyridine derivatives as soft rock inhibitors (2017-06-20),

RedX Pharma Limited is a leading pharmaceutical company specializing in the development of innovative and effective drug therapies. With a strong focus on research and development, RedX Pharma is dedicated to addressing unmet medical needs and improving patient outcomes. Our talented team of scientists and healthcare professionals work tirelessly to discover and develop novel drugs targeting various diseases including cancer, infectious diseases, and immune disorders. We aim to transform healthcare through the delivery of safe and effective treatments that positively impact patients’ lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

26 Patents

#9 in Manchester

#678 in United Kingdom

#24,093 in the World

Manchester, United Kingdom

Redx Pharma Limited

Forward Citations = 73

40 inventors:

Inder Bhamra (9 out of 10 patents)

Richard Testar (8 out of 9 patents)

Craig Donoghue (7 out of 7 patents)

4. Matilda Bingham (6 out of 7 patents)

5. David John Moody (6 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…